Turn this role into an interview — a resume and cover letter built around what this employer wants.
Amgen Inc. is seeking a Senior Engineer to lead cleaning and sterilization engineering across the global network, focusing on CIP/SIP, caustic cleaning, and related systems.
This role is part of the ETA on the Drug Substance Process Engineering team and supports ANC2 capital projects with design, start-up, and operations support. You will drive standardization, engineering excellence, and digitalization of cleaning systems while collaborating with Operations and external consultants.
Let’s do this. Let’s change the world. In this vital role you will provide engineering leadership and technical expertise for the planning, design, construction, start-up, and operational support of Drug Substance Cleaning & Sterilization systems across Amgen’s global manufacturing and development network. The role will focus on Clean-in-Place (CIP), Steam-in-Place (SIP), caustic cleaning, and related cleaning and sterilization technologies. The Senior Engineer will be a member of the Engineering Technical Authority (ETA) on the Drug Substance Process Engineering team. ETA provides global technical direction, leadership, guidance, and engineering support for process systems throughout Amgen’s manufacturing and development network. In this role, you will support initiatives that deliver robust, reliable, and standardized cleaning and sterilization capabilities across the network.
The immediate focus of this role will be supporting the Amgen North Carolina 2 (ANC2) Capital Project. The Senior Engineer will be responsible for the successful design, construction, commissioning, and start-up of the facility’s cleaning and sterilization scope. Key systems and responsibilities will include three CIP skids and their associated cleaning circuits, plant-wide SIP operations, downstream caustic cleaning operations, and glass wash and autoclave systems.
Travel up to 30%.
We are all different, yet we all use our unique contributions to serve patients. The Engineer professional we seek is a collaborative individual with these qualifications.
As we work to develop treatments that take care of others, we also work to care for your professional and personal growth and well‑being. From our competitive benefits to our collaborative culture, we’ll support your journey every step of the way.
Refer to the Work Location Type in the job posting to see if this applies.
The expected annual salary range for this role in the U.S. (excluding Puerto Rico) is posted. Actual salary will vary based on several factors including but not limited to, relevant skills, experience, and qualifications. In addition to the base salary, Amgen offers a Total Rewards Plan, based on eligibility.
Salary Range 115,494.60 USD - 156,257.40 USD
Sponsorship for this role is not guaranteed.
Amgen is an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or any other basis protected by applicable law. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.